Articles

Novo Nordisk is cutting prices on weight-loss drug Wegovy, a week after Eli Lilly did the same for rival Zepbound.

Tesla has its second straight difficult month in Germany, as data released Wednesday showed that vehicle registrations fell 76% in February in Europe’s largest economy.

President Donald Trump, fresh from his clash with President Volodymyr Zelensky of Ukraine, is eyeing America’s mineral wealth.

Palantir’s stock trades at a “frothy” multiple, but one former critic says his view on valuation has evolved somewhat.

U.S. businesses created just 77,000 new jobs in February, paycheck company ADP said, in a sign the economy could be slowing as businesses weighed how to respond to President Trump ‘s plan to boost tariffs.

Abercrombie & Fitch also approved a $1.3 billion share repurchase program including $400 million in 2025.

Foot Locker’s stock was tripped up by downbeat full-year outlook, which offset continued sales improvements.

The incredible thing about Germany’s finances is that planned extra spending of about $1 trillion still would put them as having the lowest debt-to-gross domestic product of the Group of Seven nations, which includes the U.S.

U.S. trading partners will exclude an isolationist America and realize that U.S. consumers can be replaced.

Mortgage applications rose 20.4% in the last week, the Mortgage Bankers Association said.

Oil futures were on track for a four-day losing streak Wednesday, extending losses on worries over prospects for a global trade war that could dent demand.

BCA Research’s Peter Berezin sees a U.S. recession on the horizon — a reason to stay out of stocks.